You can now read 5 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

Mass. Movers

Idera surges on positive drug-test results

Psoriasis occurs when the immune system sees skin cells as a pathogen.


Psoriasis occurs when the immune system sees skin cells as a pathogen.

Continue reading below

Cambridge-based Idera Pharmaceuticals Inc. reported its lead drug candidate, for moderate to severe plaque psoriasis, was more effective than a placebo in a Phase 2a clinical trial. Idera said 48 percent of patients with the condition (12 of 25) treated with IMO-3100 demonstrated improvement. The trial involved two dose levels of the drug administered for four weeks, with a four-week follow-up. None of the 12 patients who got placebos showed significant improvement.

Loading comments...
Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
Please enter a valid email will never post anything without asking.
Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of